[High mortality in hemorrhagic stroke--new therapeutic principles should be tested].
Nilsson
Ola G
OG
Neurokirurgiska kliniken, Universitetssjukhuset i Lund. ola.nilsson@neurokir.lu.se
D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003399:Craniotomy / Q000379:methods; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D006408:Hematoma, Subdural / Q000209:etiology / Q000401:mortality / Q000628:therapy; D006801:Humans; D002532:Intracranial Aneurysm / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery; D020300:Intracranial Hemorrhages / Q000209:etiology / Q000401:mortality* / Q000628:therapy; D008297:Male; D008866:Microsurgery / Q000379:methods; D020521:Stroke / Q000150:complications / Q000401:mortality* / Q000628:therapy; D013345:Subarachnoid Hemorrhage / Q000209:etiology / Q000401:mortality* / Q000628:therapy; D014057:Tomography, X-Ray Computed
D000933:Antifibrinolytic Agents